David Newman is a scholar working on Nephrology, Infectious Diseases and Organic Chemistry.
According to data from OpenAlex, David Newman has authored 2 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 1 paper in Nephrology, 0 papers in Infectious Diseases and 0 papers in Organic Chemistry. Recurrent topics in David Newman's work include Chronic Kidney Disease and Diabetes (1 paper), Dialysis and Renal Disease Management (1 paper) and Acute Kidney Injury Research (1 paper). David Newman is often cited by papers focused on Chronic Kidney Disease and Diabetes (1 paper), Dialysis and Renal Disease Management (1 paper) and Acute Kidney Injury Research (1 paper). David Newman collaborates with scholars based in Sweden. David Newman's co-authors include Hansa Thakkar, R. G. EDWARDS, Anders Grubb, Martin Wilkie, Christopher P. Price, Thomas E. White and Daniel J. Kleitman and has published in prestigious journals such as Kidney International and American Mathematical Monthly.
In The Last Decade
David Newman
2 papers
receiving
503 citations
Hit Papers
What are hit papers?
Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine
1995524 citationsDavid Newman, Hansa Thakkar et al.Kidney Internationalprofile →
Citations per year, relative to David Newman David Newman (= 1×)
peers
L Faccini
Countries citing papers authored by David Newman
Since
Specialization
Citations
This map shows the geographic impact of David Newman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Newman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Newman more than expected).
This network shows the impact of papers produced by David Newman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Newman. The network helps show where David Newman may publish in the future.
Co-authorship network of co-authors of David Newman
This figure shows the co-authorship network connecting the top 25 collaborators of David Newman.
A scholar is included among the top collaborators of David Newman based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with David Newman. David Newman is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
2 of 2 papers shown
1.
Newman, David, Hansa Thakkar, R. G. EDWARDS, et al.. (1995). Serum cystatin C measured by automated immunoassay: A more sensitive marker of changes in GFR than serum creatinine. Kidney International. 47(1). 312–318.524 indexed citations breakdown →
2.
Newman, David & Daniel J. Kleitman. (1991). E3274. American Mathematical Monthly. 98(10). 958–958.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.